Literature DB >> 11037193

Diffuse Lewy body disease.

K Kosaka1.   

Abstract

Diffuse Lewy body disease (DLBD) has been studied from various viewpoints and, although clinical diagnostic criteria for DLBD have been proposed, diagnosis remains difficult. DLBD has been reported to be the second most common form of dementia in the aged, following Alzheimer-type dementia. It has, however, been clinically under-diagnosed. Therefore, the search for diagnostic markers for DLBD must continue. Very recently, 'dementia with Lewy bodies' (DLB) was proposed as a generic term for various forms of dementia with Lewy bodies, including DLBD and similar disorders. Cortical Lewy bodies are the most important pathologic marker for diagnosis of DLBD. At present, however, the mechanism responsible for cortical Lewy body formation has yet to be disclosed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037193     DOI: 10.1046/j.1440-1789.2000.00301.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  4 in total

1.  Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.

Authors:  Naoya Aoki; Melissa E Murray; Kotaro Ogaki; Shinsuke Fujioka; Nicola J Rutherford; Rosa Rademakers; Owen A Ross; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-11-04       Impact factor: 17.088

Review 2.  Sleep, Cognition and Dementia.

Authors:  Verna R Porter; William G Buxton; Alon Y Avidan
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

3.  Beta-synuclein gene alterations in dementia with Lewy bodies.

Authors:  H Ohtake; P Limprasert; Y Fan; O Onodera; A Kakita; H Takahashi; L T Bonner; D W Tsuang; I V J Murray; V M-Y Lee; J Q Trojanowski; A Ishikawa; J Idezuka; M Murata; T Toda; T D Bird; J B Leverenz; S Tsuji; A R La Spada
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

Review 4.  Lewy body disease and dementia with Lewy bodies.

Authors:  Kenji Kosaka
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2014       Impact factor: 3.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.